These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 6546655

  • 1. [Systemic chemotherapy of mammary carcinoma: plasma and tissue concentrations of 5-fluorouracil and adriamycin, and result of CAF and CMF therapy of breast cancer].
    Murayama Y, Nagashima M.
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):415-9. PubMed ID: 6546655
    [Abstract] [Full Text] [Related]

  • 2. Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.
    Hainsworth JD, Jolivet J, Birch R, Hopkins LG, Greco FA.
    Cancer; 1997 Feb 15; 79(4):740-8. PubMed ID: 9024712
    [Abstract] [Full Text] [Related]

  • 3. Acquisition of multidrug resistance in recurrent breast cancer demonstrated by the histoculture drug response assay.
    Tanino H, Oura S, Hoffman RM, Kubota T, Furukawa T, Arimoto J, Yoshimasu T, Hirai I, Bessho T, Suzuma T, Sakurai T, Naito Y.
    Anticancer Res; 2001 Feb 15; 21(6A):4083-6. PubMed ID: 11911296
    [Abstract] [Full Text] [Related]

  • 4. [Combination chemotherapy of cyclophosphamide adriamycin and 5-fluorouracil (CAF) in advanced and recurrent breast cancer].
    Abe O, Izuo M, Enomoto K, Kubo K, Koyama H, Sakai K, Terasawa T, Tominaga T, Nomura Y.
    Gan To Kagaku Ryoho; 1982 May 15; 9(5):866-73. PubMed ID: 7184431
    [Abstract] [Full Text] [Related]

  • 5. [5-Fluorouracil concentration in various tissues from cancer patients after oral administration of 5-fluorouracil].
    Nakamura T, Hashimoto I, Sawada Y, Mikami J, Yoshimoto M, Nishidai H, Nakanishi Y, Kashi Y.
    Gan To Kagaku Ryoho; 1984 May 15; 11(5):1037-48. PubMed ID: 6721512
    [Abstract] [Full Text] [Related]

  • 6. [CMF or CAF combination chemotherapy for breast cancer].
    Ota J.
    Gan To Kagaku Ryoho; 1996 Dec 15; 23(14):1886-90. PubMed ID: 8978791
    [Abstract] [Full Text] [Related]

  • 7. [Effects of combination chemotherapy M-VEMFH including mitoxantrone in advanced breast cancer].
    Ito Y, Hoshino A, Ohara K, Kamiya O, Nagata K, Kojima T, Kinoshita T, Sugiura I.
    Gan To Kagaku Ryoho; 1985 Oct 15; 12(10):1999-2003. PubMed ID: 4051516
    [Abstract] [Full Text] [Related]

  • 8. Dofequidar fumarate (MS-209) in combination with cyclophosphamide, doxorubicin, and fluorouracil for patients with advanced or recurrent breast cancer.
    Saeki T, Nomizu T, Toi M, Ito Y, Noguchi S, Kobayashi T, Asaga T, Minami H, Yamamoto N, Aogi K, Ikeda T, Ohashi Y, Sato W, Tsuruo T.
    J Clin Oncol; 2007 Feb 01; 25(4):411-7. PubMed ID: 17179098
    [Abstract] [Full Text] [Related]

  • 9. Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140.
    Parnes HL, Cirrincione C, Aisner J, Berry DA, Allen SL, Abrams J, Chuang E, Cooper MR, Perry MC, Duggan DB, Szatrowski TP, Henderson IC, Norton L, Cancer and Leukemia Group B.
    J Clin Oncol; 2003 May 01; 21(9):1819-24. PubMed ID: 12721259
    [Abstract] [Full Text] [Related]

  • 10. [Feasibility of a cyclophosphamide methotrexate and 5-fluorouracil regime intravenously administered with and without granulocyte-colony stimulating factor in surgically treated breast carcinoma].
    Garrone O, Del Mastro L, Mariani GL, Ardizzoni A, Venturini M, Rosso R.
    Minerva Med; 1993 Sep 01; 84(9):467-72. PubMed ID: 7504219
    [Abstract] [Full Text] [Related]

  • 11. [Adriamycin--breast cancer].
    Nomura Y.
    Gan To Kagaku Ryoho; 1996 Dec 01; 23(14):1911-5. PubMed ID: 8978796
    [Abstract] [Full Text] [Related]

  • 12. [A study on the efficacy of combination chemoendocrine therapy consisting of cyclophosphamide, adriamycin, UFT, and tamoxifen for advanced or recurrent breast cancer].
    Yamaguchi S, Fukuda M, Ota T, Nakayama Y, Ogata H, Shimizu K, Nishikawa T, Adachi Y, Fukuma E.
    Gan To Kagaku Ryoho; 1999 Jul 01; 26(8):1145-52. PubMed ID: 10431580
    [Abstract] [Full Text] [Related]

  • 13. Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial.
    Leonard RC, Lind M, Twelves C, Coleman R, van Belle S, Wilson C, Ledermann J, Kennedy I, Barrett-Lee P, Perren T, Verrill M, Cameron D, Foster E, Yellowlees A, Crown J, Anglo-Celtic Cooperative Oncology Group.
    J Natl Cancer Inst; 2004 Jul 21; 96(14):1076-83. PubMed ID: 15265969
    [Abstract] [Full Text] [Related]

  • 14. Prolonged disease-free survival in advanced breast cancer treated with "super-CMF" adriamycin: an alternating regimen employing high-dose methotrexate with citrovorum factor rescue.
    Henderson IC, Gelman R, Canellos GP, Frei E.
    Cancer Treat Rep; 1981 Jul 21; 65 Suppl 1():67-75. PubMed ID: 6976832
    [Abstract] [Full Text] [Related]

  • 15. [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting].
    Inaji H, Sakai K, Oka T, Ozawa K, Saito Y, Senoo T, Taguchi T, Terasawa T, Nakao K, Mori T, Koyama H, Oshima A.
    Gan To Kagaku Ryoho; 2006 Oct 21; 33(10):1423-9. PubMed ID: 17033231
    [Abstract] [Full Text] [Related]

  • 16. Antitumor effect of combination of cyclophosphamide, adriamycin and platinum (CAP) versus cyclophosphamide, adriamycin and 5-fluorouracil (CAF) in metastatic breast cancer.
    Tzekova V, Velikova M, Koynov K, Micheva D, Donchev T.
    Neoplasma; 1991 Oct 21; 38(6):603-7. PubMed ID: 1766485
    [Abstract] [Full Text] [Related]

  • 17. [Chemotherapy for recurrent breast carcinoma].
    Taguchi T.
    Gan To Kagaku Ryoho; 1985 Mar 21; 12(3 Pt 1):439-47. PubMed ID: 4004279
    [Abstract] [Full Text] [Related]

  • 18. Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.
    Dhingra K, Frye D, Newman RA, Walters R, Theriault R, Fraschini G, Smith T, Buzdar A, Hortobagyi GN.
    Clin Cancer Res; 1995 Jul 21; 1(7):691-7. PubMed ID: 9816034
    [Abstract] [Full Text] [Related]

  • 19. [The clinical efficacy of CAC regimen in the treatment of advanced breast cancer].
    Zhang P, Zhou J, Feng F.
    Zhonghua Zhong Liu Za Zhi; 1995 Sep 21; 17(5):365-7. PubMed ID: 8697977
    [Abstract] [Full Text] [Related]

  • 20. [Clinical evaluation of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) on advanced and recurrent breast cancer. Clinical study group of CMF for breast cancer in Japan].
    Nomura Y, Tominaga T, Adachi I, Koyama H, Fukami A.
    Gan To Kagaku Ryoho; 1994 Sep 21; 21(12):1949-56. PubMed ID: 8085846
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.